SXR8.DE vs. 2B70.DE
SXR8.DE (iShares Core S&P 500 UCITS ETF USD (Acc)) and 2B70.DE (iShares Nasdaq US Biotechnology UCITS ETF) are both exchange-traded funds - SXR8.DE is a S&P 500 fund tracking the S&P 500 Index, while 2B70.DE is a Health & Biotech Equities fund tracking the Nasdaq Biotechnology. Both are passively managed. Over the past 5 years, SXR8.DE returned 14.24%/yr vs 4.63%/yr for 2B70.DE. A 0.60 correlation means they provide meaningful diversification when combined. SXR8.DE charges 0.07%/yr vs 0.35%/yr for 2B70.DE.
Performance
SXR8.DE vs. 2B70.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SXR8.DE achieves a 9.96% return, which is significantly higher than 2B70.DE's 5.03% return.
SXR8.DE
- 1D
- 1.56%
- 1M
- 0.60%
- YTD
- 9.96%
- 6M
- 11.01%
- 1Y
- 24.90%
- 3Y*
- 17.96%
- 5Y*
- 14.24%
- 10Y*
- 14.87%
2B70.DE
- 1D
- 0.94%
- 1M
- 2.60%
- YTD
- 5.03%
- 6M
- 6.22%
- 1Y
- 38.82%
- 3Y*
- 10.15%
- 5Y*
- 4.63%
- 10Y*
- —
SXR8.DE vs. 2B70.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SXR8.DE iShares Core S&P 500 UCITS ETF USD (Acc) | 9.96% | 4.73% | 32.32% | 22.47% | -14.31% | 40.74% | 6.80% | 34.49% | -1.05% | 3.63% |
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 5.03% | 18.57% | 4.69% | 2.49% | -6.33% | 7.72% | 14.37% | 30.21% | -7.20% | -19.24% |
Correlation
The correlation between SXR8.DE and 2B70.DE is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.44 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.48 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.53 |
Correlation (All Time) Calculated using the full available price history since Oct 19, 2017 | 0.60 |
The correlation between SXR8.DE and 2B70.DE shifts across timeframes, from 0.44 (1 year) to 0.60 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SXR8.DE vs. 2B70.DE — Risk / Return Rank
SXR8.DE
2B70.DE
SXR8.DE vs. 2B70.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Core S&P 500 UCITS ETF USD (Acc) (SXR8.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SXR8.DE | 2B70.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.09 | ||
| Sortino ratioReturn per unit of downside risk | +0.04 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.33 | +0.05 |
| Calmar ratioReturn relative to maximum drawdown | 3.52 | 6.16 | -2.64 |
| Martin ratioReturn relative to average drawdown | 12.50 | 17.53 | -5.03 |
Loading charts...
Drawdowns
SXR8.DE vs. 2B70.DE - Drawdown Comparison
The maximum SXR8.DE drawdown since its inception was -33.78%, which is greater than 2B70.DE's maximum drawdown of -30.92%. Use the drawdown chart below to compare losses from any high point for SXR8.DE and 2B70.DE.
Loading charts...
Drawdown Indicators
| SXR8.DE | 2B70.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -33.78% | -30.92% | -2.86% |
Max Drawdown (1Y)Largest decline over 1 year | -6.94% | -6.28% | -0.66% |
Max Drawdown (3Y)Largest decline over 3 years | -23.32% | -29.42% | +6.10% |
Max Drawdown (5Y)Largest decline over 5 years | -23.32% | -30.92% | +7.60% |
Max Drawdown (10Y)Largest decline over 10 years | -33.78% | — | — |
Current DrawdownCurrent decline from peak | -1.72% | -0.79% | -0.93% |
Average DrawdownAverage peak-to-trough decline | -5.22% | -11.80% | +6.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.96% | 2.17% | -0.21% |
Volatility
SXR8.DE vs. 2B70.DE - Volatility Comparison
The current volatility for iShares Core S&P 500 UCITS ETF USD (Acc) (SXR8.DE) is 3.08%, while iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) has a volatility of 6.57%. This indicates that SXR8.DE experiences smaller price fluctuations and is considered to be less risky than 2B70.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SXR8.DE | 2B70.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.08% | 6.57% | -3.49% |
Volatility (6M)Calculated over the trailing 6-month period | 7.86% | 14.63% | -6.77% |
Volatility (1Y)Calculated over the trailing 1-year period | 11.78% | 19.40% | -7.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.18% | 20.43% | -5.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.08% | 22.35% | -6.27% |
SXR8.DE vs. 2B70.DE - Expense Ratio Comparison
SXR8.DE has a 0.07% expense ratio, which is lower than 2B70.DE's 0.35% expense ratio.
Dividends
SXR8.DE vs. 2B70.DE - Dividend Comparison
Neither SXR8.DE nor 2B70.DE has paid dividends to shareholders.
Frequently Asked Questions
SXR8.DE and 2B70.DE have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, SXR8.DE is cheaper at 0.07% per year. The better choice depends on whether you care most about return, fees, risk, or income.
SXR8.DE is cheaper with a 0.07% expense ratio, compared with 0.35% for 2B70.DE.
SXR8.DE is categorized as S&P 500, while 2B70.DE is Health & Biotech Equities. SXR8.DE tracks S&P 500 Index, while 2B70.DE tracks Nasdaq Biotechnology. Their fees differ too: 0.07% for SXR8.DE and 0.35% for 2B70.DE.
Find the right allocation for SXR8.DE and 2B70.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer